Biotech | January 15, 2025
MRX-5 is a novel benzoxazole antibiotic developed for the treatment of mycobacteria infections, particularly infections caused by non-tuberculous Mycobacteria
Ordspono is Regeneron’s first approved bispecific antibody and will provide an off-the-shelf option that can be administered in the out-patient setting, with hope for complete remission
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
Application based on the Transcend FL trial in which Breyanzi showed deep and durable responses and a consistent and well-established safety profile
Both departments will be equipped with specialized professionals and state-of-the-art facilities ensuring the highest standards of care
Access to breast milk for sick newborns admitted in intensive care units plays a lifesaving role
Poly Medicure has reported total income of Rs. 401.69 crores during the period ended June 30, 2024
Poly Medicure has reported total income of Rs. 351.38 crores during the period ended September 30, 2023
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
Subscribe To Our Newsletter & Stay Updated
